Sagent Pharmaceuticals, Inc., a provider of specialty pharmaceutical products with an emphasis on the injectable market, has acquired Omega Laboratories Limited, a  specialty pharmaceutical company based in Montreal, Canada. The transaction closed on October 1, 2014, Sagent acquired Omega for approximately US$85.3 million (C$95 million) in an all-cash deal. 

Omega, founded in 1958, provides generic injectable and specialty pharmaceuticals, Over the last three years,the company has produced a compound annual growth rate (CAGR) of 22.6%, and its 2013 revenues were C$36.5 million ($32.4 million). Omega markets 93 products in more than 40 countries, in key markets in Europe and Asia. In addition, Omega’s pipeline consists of 26 generic injectable drugs scheduled to be launched between 2014 and 2019.

Source: Sagent Pharmaceuticals